---
schema_version: "secwatch.filing_event.v1"
accession: "0001410098-26-000040"
form_type: "8-K"
ticker: "CRMD"
cik: "0001410098"
company_name: "CorMedix Inc."
filed_at: "2026-07-02T20:30:35+00:00"
generated_at: "2026-07-02T20:33:37.697503+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CorMedix appoints Elizabeth Hurlburt as Chief Operating and Commercial Officer; Michael Seckler departs

## Summary
- Elizabeth Hurlburt, previously COO, appointed to newly created role of Chief Operating and Commercial Officer, effective June 29, 2026.
- Hurlburt will oversee commercial, medical affairs, regulatory, and clinical functions, reporting to Chairman & CEO Joseph Todisco.
- Michael Seckler has left the Company as part of the leadership restructuring.

## SEC filing metadata
- accession: 0001410098-26-000040
- form_type: 8-K
- ticker: CRMD
- cik: 0001410098
- company_name: CorMedix Inc.
- filed_at: 2026-07-02T20:30:35+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1410098/000141009826000040/0001410098-26-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1410098/000141009826000040/crmd-20260629.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001410098-26-000040
- JSON: https://secwatch.observer/filing/0001410098-26-000040.json
- Plain text: https://secwatch.observer/filing/0001410098-26-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.